the aid library

LIST OPTIONS

Filter

8524

Sort by:

Direction:

Download (210)

View PDF (453)

GLI model TB diagnostic algorithms

Global Laboratory Initiative World Health Organization (2015) C_WHO

Download (55)

View PDF (98)

Factors associated with HIV counseling and testing behavior among undergraduates of universities and vocational technical training schools in Tbilisi, Georgia

M. Djibuti; T. Zurashvili; T. Kasrashvili; C. J. Berg BMC Public Health (BioMed Central) (2015) CC

Djibuti et al. BMC Public Health (2015) 15:427 DOI 10.1186/s12889-015-1760-z

Download (611)

View PDF (1342)

WHO Ebola R&D Effort – vaccines, therapies, diagnostics

World Health Organization (2015)

Download (1182)

View PDF (1442)

Nutrition Topic Guide

Jessica Meeker, Stephen Thompson, Inka Barnett The Health & Education Advice & Resource Team (HEART) (2013)

This Topic Guide has been compiled to provide an overview of undernutrition in the context of development. The focus of the Guide is on undernutrition, defined as the outcome of insufficient (quantity and quality) of food intake (hunger) and repeated infectious diseases. Undernutrition includes bein... more

Download (350)

View PDF (618)

Tuberculosis laboratory biosafety manual

World Health Organization (2012) C_WHO

Download (649)

View PDF (756)

Water, Sanitation and Hygiene (WASH) in Schools

World Health Organization (WHO) (2012) C_WHO

A companion to the Child Friendly Schools Manual
WASH in Schools aims to improve the health and learning performance of school-aged children – and, by extension, that of their families – by reducing the incidence of water and sanitation-related diseases. Every child friendly school r... more

Download (87)

View PDF (114)

Street-based adolescents at high risk of HIV in Ukraine

J. R. Busza; O. M. Balakireva; A. Teltschik; et al. J Epidemiol Community Health; Research Gate (2011) C2

J Epidemiol Community Health 2011;65:1166e1170. doi:10.1136/jech.2009.097469

Download (750)

View PDF (1173)

Nigeria Integrated Biological and Behavioural Surveillance Survey (IBBSS) 2010

Federal Ministry of Health, Nigeria (2010) C1

Download (1115)

View PDF (1899)

Practical Pharmacy for Developing Countries No.18

Bower, J. World Health Organization WHO (2008) C_WHO

Download (2093)

View PDF (2390)

Epidemiology and Management of Common Skin Diseases in Children in Developing Countries

World Health Organization WHO (2005) C_WHO

Download (927)

View PDF (2292)

Ensuring Food Safety In The Aftermath Of Natural Disasters

World Health Organization (2004)

Download (118)

View PDF (93)

Pediatric Oncology nursing practice in Latin America and the Carribbean

World Health Organization WHO (2023) C_WHO

This technical report has been developed within the framework of the WHO Global Initiative for Childhood Cancer. Its goal is to improve the situation of children and adolescents with cancer worldwide, giving them the best chances of survival, living a full life and, above all, enjoying quality of ... more

Download (176)

View PDF (247)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (432)

View PDF (523)

Accelerating WHO FCTC Implementation in the WHO South-East Asia Region: A Practical Approach

World Health Organization (WHO), Regional Office for South-East-Asia (2017) C_WHO

The WHO Framework Convention on Tobacco Control (‎WHO FCTC)‎ is an evidence-based treaty that reaffirms the right of all people to the highest standard of health and was developed in response to the globalization of the tobacco epidemic. Member States of the WHO South-East Asia Region have made... more

Download (222)

View PDF (428)

International Standards of Drug Use Prevention

World Health Organization (WHO); United Nations Office on Drug and Crime UNODC (2019) C_WHO

2nd revised edition. Accessed Apri. 17, 2019 Prevention strategies based on scientific evidence working with families, schools, and communities can ensure that children and youth, especially the most marginalized and poor, grow and stay healthy and safe into adulthood and old age. For every dollar ... more

Download (111)

View PDF (145)

Вывести из забвения для достижения. Целей в области устойчивого развития Механизм мониторинга и оценки прогресса для д орожной карты по борьбе с забытыми тропическими болезнями на 2021–2030 гг

World Health Organization WHO (2021) C_WHO

В дорожной карте по борьбе с забытыми тропическими болезнями на 2021–2030 гг. («дорожная карта») определены глобальные цели и основные этапы в отношении борьбы с 20 бол�... more

Download (213)

View PDF (238)

Ending the neglect to attain the Sustainable Development Goals: A road map for neglected tropical diseases 2021–2030

World Health Organization WHO (2021) C_WHO

The road map sets global targets and milestones to prevent, control, eliminate or eradicate 20 diseases and disease groups as well as cross-cutting targets aligned with the Sustainable Development Goals. Three foundational pillars will support global efforts to achieve the targets: accelerate progra... more

Download (74)

View PDF (111)

“Crafting the mosaic” A framework for resilient surveillance for respiratory viruses of epidemic and pandemic potentia

World Health Organisation (WHO) (2023) C_WHO

It is impossible to address the many complex needs of respiratory virus surveillance with a single surveillance system. Multiple systems, investigations and studies must each be fit-for-purpose to specific priority surveillance objectives, and only together can they provide essential information to ... more

Download (75)

View PDF (332)

Critically important antimicrobials for human medicine: 6th Revision 2018

World Health Organization WHO (2018) C_WHO

The WHO CIA List should be used as a reference to help formulate and prioritize risk assessment and risk management strategies for containing antimicrobial resistance. The WHO CIA List supports strategies to mitigate the human health risks associated with antimicrobial use in ... more

Download (618)

View PDF (962)

Global Framework for Development & Stewardship to Combat Antimicrobial Resistance

World Health Organization WHO (2017) C_WHO

Draft Roadmap